Delivery Order SPE2DB20D2104-SPE2DB25FMCCT

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order valued at $3,754.96 and has an ultimate completion date of October 30, 2024. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product used for the treatment of diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award, valued at $31,159.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of JARDIANCE 25 MG TABLET 90S, a diabetes medication. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
This federal contract award, valued at $7,938.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order type, with a Firm Fixed Price pricing structure, and an ultimate completion date of November 25, 2024. The contract covers the procurement of JARDIANCE 25 MG TABLET 90S, a medical product used for diabetes management. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is a delivery order with a firm fixed-price valued at $12,813.72, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,726.93 firm fixed-price delivery order contract is for the supply of JARDIANCE 25 MG TABLET 90S, a medical product. The contract has an ultimate completion date of January 3, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,569.86 firm fixed-price delivery order covers the supply of JARDIANCE 25 MG TABLET 90S, a medication used to treat diabetes. The contract has an ultimate completion date of October 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,264.61 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a prescription medication. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,197.40 firm fixed-price delivery order is for the provision of JARDIANCE 25 MG TABLET 90S, a medication used in the treatment of diabetes. The contract has an ultimate completion date of November 30, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,158.10 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a medication used for the treatment of diabetes. The contract has a completion date of February 7, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,063.41 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a medication used to manage diabetes. The award does not have a set-aside designation, indicating open competition. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMCCT
    Delivery Order

This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $16,517.06 and a completion date of November 18, 2024. The contract is with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide JARDIANCE 25 MG TABLET 90S, a medication used for diabetes management.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:06 PM